A Low-Resource Oxygen Blender Prototype for Use in Modified Bubble CPAP Circuits
1 other identifier
interventional
33
1 country
1
Brief Summary
Purpose: Using a novel oxygen blender prototype with modified bCPAP to manage children 1 month to 5 years of age hospitalized with respiratory distress due to lower respiratory tract infection (LRTI) in low-resource settings is not associated with clinical failure within 1 hour of use. Aim: To investigate if this novel oxygen blender is safe to use among children 1 month to 5 years old hospitalized for respiratory distress from lower respiratory tract infections in a low-resource setting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 5, 2020
CompletedFirst Posted
Study publicly available on registry
March 17, 2020
CompletedStudy Start
First participant enrolled
March 26, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 28, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedApril 15, 2024
April 1, 2024
1 year
March 5, 2020
April 12, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Feasibility as Measured by Clinical Failure
The primary outcome of this study is the feasibility of the investigational device as measured by clinical failure within 1 hour of installing the blender in the bubble continuous positive airway pressure (bCPAP) circuit. Clinical failure is defined as the occurrence of any of the following patient events: intubation, death, or transfer for higher level of care, or any 2 of the following events; \<85% O2 saturation after 30 min of treatment, new signs of respiratory distress, or partial pressure of carbon dioxide greater than 60 mmHg and pH less than 7.2 in capillary blood gas. Outcome will be reported as the percent of participants who experience clinical failure within 1 hour after blender installation.
1 hour
Secondary Outcomes (9)
Oxygen Saturation
Approximately 7 days
Oxygen Concentration of Outflow
Approximately 7 days
Flow of Oxygen from Tank
Approximately 7 days
Continuous Positive Air Pressure (CPAP) Level
Approximately 7 days
Bubble Continuous Positive Air Pressure (bCPAP) Maintenance
Approximately 7 days
- +4 more secondary outcomes
Study Arms (1)
Low-Resource Oxygen Blender
EXPERIMENTALThis is a single-arm study. All participants will receive respiratory support using the investigational device.
Interventions
The device that is being evaluated is a novel low-cost, high access oxygen blender designed to be used in the World Health Organization bCPAP design. It functions by utilizing the Venturi effect, whereby a narrow jet of one fluid (i.e. oxygen) creates a suction effect and entrains surrounding ambient fluid (i.e. room air) into the jet, effectively creating a mixed solution of both fluids. The cost of materials amounts to approximately 1.40 U.S.D. The average time it takes to build a blender and incorporate it into a bCPAP circuit for a new user is approximately 16 minutes. The materials can all be found in a standard hospital, namely 3cc syringes with rubber stops and a 22 gauge hypodermic needle.
Eligibility Criteria
You may qualify if:
- Admitted for lung disease and require hospitalization
- Admission diagnosis is lower respiratory tract infection or pneumonia or bronchiolitis (any infectious microbe including bacterial, viral, fungal, parasitic)
- Have respiratory distress on presentation to the hospital (cough or trouble breathing plus at least one of the following: \<92% despite low flow oxygen, central cyanosis, tachypnea, chest indrawing, nasal flaring, grunting, head nodding, convulsions, lethargy, inability to breastfeed or drink)
- A bCPAP (electronic) machine is not available to use
You may not qualify if:
- History of asthma
- Upper airway obstruction
- Diaphragmatic hernia
- Pneumothorax
- Acute Glasgow Coma score \<4
- Cleft Palate
- Cyanotic heart disease
- Bleeding disorders
- Imminent death within 2 hours
- Have had abdominal or thoracic surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chenla Children's Healthcare
Kratié, Kratié Province, 10109, Cambodia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrew Wu, MD, MPH
University of Minnesota
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 5, 2020
First Posted
March 17, 2020
Study Start
March 26, 2022
Primary Completion
March 28, 2023
Study Completion
December 31, 2023
Last Updated
April 15, 2024
Record last verified: 2024-04